Cargando…
The Shigella Vaccines Pipeline
Shigella is the leading cause of global diarrheal deaths that currently lacks a licensed vaccine. Shigellosis drives antimicrobial resistance and leads to economic impact through linear growth faltering. Today, there is a robust pipeline of vaccines in clinical development which are broadly divided...
Autores principales: | MacLennan, Calman Alexander, Grow, Stephanie, Ma, Lyou-fu, Steele, Andrew Duncan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504713/ https://www.ncbi.nlm.nih.gov/pubmed/36146457 http://dx.doi.org/10.3390/vaccines10091376 |
Ejemplares similares
-
Frontiers in Shigella Vaccine Development
por: MacLennan, Calman Alexander, et al.
Publicado: (2022) -
Pivotal Shigella Vaccine Efficacy Trials—Study Design Considerations from a Shigella Vaccine Trial Design Working Group
por: Pavlinac, Patricia B., et al.
Publicado: (2022) -
Salmonella Combination Vaccines: Moving Beyond Typhoid
por: MacLennan, Calman A, et al.
Publicado: (2023) -
Consensus Report on Shigella Controlled Human Infection Model: Introduction and Overview
por: MacLennan, Calman A, et al.
Publicado: (2019) -
Typhoid Conjugate Vaccines and Enteric Fever Control: Where to Next?
por: Steele, A Duncan, et al.
Publicado: (2020)